Professor, Interventional Cardiology, VGH, UBC. Tweets are my own🇨🇦. Mom/Cyclist/Runner #SCAD, #vanscad, #canscad, #LAAC, #LAAO, #FMD

Vancouver, BC, Canada
1
211
Still time to register for this weekends conference at vanscad.ca
115
Jacqueline Saw retweeted
1
211
Jacqueline Saw retweeted
Premenopausal women with ACS are often labeled “low risk.” The reality: rising MI rates, more delays and misdiagnoses, and worse outcomes vs men. ACS in younger women is different and needs tailored care, earlier recognition, and equity in treatment. ahajournals.org/doi/10.1161/…
11
21
1,100
Privileged to take part in an outstanding #ACC26 session on #LAAO. A rigorous, balanced and forward-looking discussion of the latest evidence and the promise of next-generation devices. @ACCinTouch @DeeDeeWangMD @cellisvandyep @MarieF_Poulin @docsaw @AGoldsweig
3
16
1,080
4
7
89
6,896
Jacqueline Saw retweeted
Congratulations Mme President @Drroxmehran 🎉🎊 💃 Looking forward to a year of many successes & growth under your leadership @ACCinTouch
We're thrilled to celebrate #TCT2026 Program Director, Dr. Roxana Mehran as she officially assumes the role of President of the American College of Cardiology at #ACC26! ✨ A visionary and trailblazer in #interventionalcardiology, Dr. Mehran's leadership and dedication to advancing cardiovascular care continue to inspire the global community. 🌎🫀 We couldn't be prouder of this well-deserved achievement and look forward to the extraordinary impact she will make in her new role. #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD
3
7
56
3,885
CHAMPION trial results. Watchman met noninferiority compared to DOAC for CV death, stroke and systemic embolization. And reduced the primary safety endpoint of non-procedural bleeding.
1
10
1,362
Jacqueline Saw retweeted
🔓 For a limited time until January 31, we are offering free promotional access to this new article in #CJC! 🌐 Intravenous thrombolysis in SCAD: insights from the Canadian SCAD Study ⬇️ onlinecjc.ca/article/S0828-2… @vanscad @docsaw @CardioUBC
4
6
585
Is SCAD genetic?" It is the single most common question I get from patients in clinic. For years, the answer was a frustrating "maybe." But we are finally moving from "bad luck" to biological mechanisms. Let's talk about the ADAMTSL4 connection and arterial fragility. 🧬🫀 #SCAD
1
5
380
In another analysis, we found a significant burden of rare variants in FMD-associated genes (e.g., F11R, TLN1) in SCAD patients compared to controls. Key takeaway: SCAD is rarely "monogenic" but heavily influenced by a cumulative burden of rare variants. google.com/search?q=jamanetw…
79
Jacqueline Saw retweeted
To date there has been no attempt to develop integrated management pathways for the diagnosis and management of premenopausal women presenting with ACS. This statement discusses key considerations for invasive angiography, revascularization, and related procedures such as arterial access, intravascular imaging, left ventricular angiography, invasive physiology, and provocative testing. ✍🏼 @docsaw @EstherSHKimMD @JohnBlakeman_RN @hollandtamis @MonSangh @MirvatAlasnag 📷 Diagnosis and management of ACS in premenopausal women.
2
15
37
2,004
Jacqueline Saw retweeted
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and are and often under-recognized patient population; this paper discusses the unique numerous challenges associated with their care. ✍🏼 @docsaw @EstherSHKimMD @JohnBlakeman_RN @hollandtamis @MonSangh @MirvatAlasnag
2
18
32
7,398